Bristol Myers Squibb (NYSE:BMY) reported positive Phase 2 QUINTESSENTIAL trial results for arlocabtagene autoleucel (arlo-cel) in adults with quadruple-class exposed relapsed and refractory multiple myeloma.
United Natural Foods (NYSE:UNFI) reported fiscal 2026 net sales of $31.2 billion, down 2% year over year, while adjusted EBITDA increased 27% to $701 million.
ABM (NYSE:ABM) reported fiscal third-quarter 2026 revenue of $2.32 billion, up 4.2% year over year, with net income rising to $49.7 million from $41.8 million in the prior-year period.
Pharvaris (NASDAQ:PHVS) reported Phase 3 CHAPTER-3 results showing once-daily oral deucrictibant XR reduced hereditary angioedema attack rates by 83% versus placebo across all HAE types after 24 weeks.
Bullish (NYSE:BLSH) reported August 2026 trading metrics showing total trading volume of $42.5 billion, up from July 2026 but below the same month in 2025.
Solaris Energy Infrastructure (NASDAQ:SEI) raised its fourth-quarter 2026 adjusted EBITDA guidance to $145 million–$180 million as the company expands power infrastructure to support rising electricity demand from data centers.
Canaan (NASDAQ:CAN) reported second quarter 2026 revenue of US$31.9 million, down from US$62.7 million in the first quarter and US$100.2 million in the same period of 2025.
Circle Internet Group (NYSE:CRCL) agreed to acquire Singapore-based B2B cross-border payments infrastructure company Tazapay, expanding its USDC payment network with a platform processing more than $25 billion in annualized payment volume.
Roivant (NASDAQ:ROIV) reported Phase 2 PHocus trial results showing mosliciguat reduced pulmonary vascular resistance by 56.3% v
Gamehaus Holdings (NASDAQ:GMHS) reported fiscal year 2026 revenue of US$104.7 million, down 11.4% from the previous year, while net income increased slightly to US$3.9 million.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
